# INFLECTRA
> **BLA125544** · Biologics License Application · Sponsor: CELLTRION INC · Approved 2016-04-05
## Drug
- **FDA Application Number:** BLA125544
- **Application type:** Biologics License Application
- **Brand name:** INFLECTRA
- **Generic name:** INFLIXIMAB-DYYB
- **Active ingredients:** INFLIXIMAB-DYYB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CELLTRION INC
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2016-04-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125544)
---
*AI Analytics · CC0 1.0*